
Eventum Orthopaedics raised £2.5 million (~USD $3.0 million) in a Series A round for its Quadsense knee replacement surgery device that lets orthopedic surgeons record the strength of a person’s quadriceps muscle. The measurement can assist surgeons when positioning a patient’s kneecap during knee replacement surgery.
The company raised an initial £1.4 million in 2021. Funds will support production, FDA marketing clearance and growing Eventum’s sales and technical team from five to twelve.
Thus far, Eventum Orthopaedics’ device has been used with robotic surgery in 20 procedures in New Zealand.
Sources: UK Tech News; Business Cloud
Eventum Orthopaedics raised £2.5 million (~USD $3.0 million) in a Series A round for its Quadsense knee replacement surgery device that lets orthopedic surgeons record the strength of a person’s quadriceps muscle. The measurement can assist surgeons when positioning a patient's kneecap during knee replacement surgery.
The company raised an...
Eventum Orthopaedics raised £2.5 million (~USD $3.0 million) in a Series A round for its Quadsense knee replacement surgery device that lets orthopedic surgeons record the strength of a person’s quadriceps muscle. The measurement can assist surgeons when positioning a patient’s kneecap during knee replacement surgery.
The company raised an initial £1.4 million in 2021. Funds will support production, FDA marketing clearance and growing Eventum’s sales and technical team from five to twelve.
Thus far, Eventum Orthopaedics’ device has been used with robotic surgery in 20 procedures in New Zealand.
Sources: UK Tech News; Business Cloud
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.